Posted originally on Sep 15, 2025 by Martin Armstrong |
Albania has adopted the world’s first AI “minister” in an attempt to combat corruption. Diella, the female-voiced AI entity, will be a “member of the Cabinet who is not present physically but has been created virtually,” Prime Minister Edi Rama stated, adding that the robot would ensure that “public tenders will be 100% free of corruption” since current government employees cannot be trusted.
Microsoft helped to assemble Dinella—red flag number one. The robot will receive access to 1 million digital documents, including sensitive government information. The advancements in AI are ingenious but not sentient. Dinella has been programmed and, therefore, is prone to biases.
The irony is that in turning to artificial intelligence, the people are acknowledging that human government has completely failed. I have said before that many have proposed replacing judges, regulators, and even politicians with AI, as if a machine will somehow be impartial. The problem, of course, is not the hardware but the software. Who writes the code? Who programs the “ethics”? If government controls the AI, then it is nothing more than an automated extension of the same corruption. AI becomes a weaponized bureaucracy, enforcing whatever the ruling elite rules.
Rama’s Socialist Party has its eyes set on European Union membership, believing it can rid its nation of corruption ahead of negotiations in 2027. It is unclear if lawmakers will have the ability to vote on Diella’s post as minister, or whether the public will have an opportunity to vote for AI-driven politicians.
Society has fallen to the point that robots are trusted more than human beings. Do people believe that a robot can properly represent them or lead? “[The] Prime Minister’s buffoonery cannot be turned into legal acts of the Albanian state,” said Gazmend Bardhi, parliamentary group leader of the Democrats.
AI is only as honest as its programmer, and if Microsoft is involved, I have little hope of Dinella’s moral coding. Appointing a robot as minister is an extremely desperate move by the Albanian government to restore public trust. This is not a technological milestone but a glaring warning of lost confidence in a failing political system.
Posted originally on Sep 15, 2025 by Martin Armstrong |
Business flees when it feels it is unwanted, and the Labour Party has created an environment that repels capital. A wave of pharmaceutical companies are pulling out of the United Kingdom due to a climate that has become “uninvestable.”
AstraZeneca has become one of the latest companies to pull back on investments due to excessive regulation and taxation. “We constantly reassess the investment needs of our company and can confirm our expansion in Cambridge is paused. We have no further comment to make,” a spokesperson said. The company decided to pause a 200 million pound ($271.26 million) investment in Cambridge that was slated to created 1,000 new jobs. The company first terminated a 450 million pound investment in northern England back in January, citing a lack of support from the UK government.
Merck Pharmaceuticals terminated a £1bn (US$1.35bn) research and development project in London and called the UK “uninvestable.” The drugmaker plans to abandon its London Bioscience Innovation Centre and the Francis Crick Institute by the end of the year due to the lack of investment in the life science industry and the overall undervaluation of innovative medicines and vaccines by successive UK governments.”
“Simply put, the UK is not internationally competitive,” a Merck spokesperson stated.
The NHS tightly regulates drug prices, yet spends only 9% of its budget on medicines compared to other OECD nations that spend between 14-20%. Only 37% of new drugs are fully reimbursed for their licensed use, whereas the figure is 90% in Germany and likely higher in the US. The government expects businesses to pay them a large portion of their revenue. Drugmakers face a 23.5% levy on new drugs as of 2025. Why would a pharmaceutical company research and develop new products in a nation that demands nearly a quarter of the profits?
Foreign investment in life sciences is down 58% since 2017 across the UK. Comparatively, investment in research and development (R&D) fell 1.9% on a global basis. Tight price controls, high government levies, and regulatory red tape have caused multi-billion-dollar investments to flee. Drugmakers are beginning to pour investments into the US instead, where they receive generous incentives and lower taxes.
I have created this site to help people have fun in the kitchen. I write about enjoying life both in and out of my kitchen. Life is short! Make the most of it and enjoy!
This is a library of News Events not reported by the Main Stream Media documenting & connecting the dots on How the Obama Marxist Liberal agenda is destroying America
Centinel2012 